MindWalk unveils longevity-focused GLP-1 program

AI-designed ‘companion therapeutic’ works alongside GLP-1 therapy through a complementary mechanism linked to healthy aging. Hot on the heels of multiple references to GLP-1 receptor agonists as longevity drugs at the recent Aging Research and Drug Discovery meeting in Copenhagen, AI-powered biotech MindWalk revealed it is moving forward with a new approach to GLP-1s that […] The post MindWalk unveils longevity-focused GLP-1 program appeared first on Longevity.Technology.